Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-81 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
filingDate |
1991-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee32e0a5ea6beb9046c036d061aae4fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e196ab2f99c3f364a11dbf30128066e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7aa6f84adcbe57025419610be0e8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8e99dd534b5f067b7c3222a9cc6c2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66902c9a136254e71e3f0977066c5bb |
publicationDate |
1992-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0470565-A1 |
titleOfInvention |
Peptides with antigenic determinant characteristic for alpha 1-microglobulin |
abstract |
A peptide according to the invention is at most 40 amino acids long and contains a sequence of at least 6 amino acids from the partial amino acid sequence between amino acids 144 and 183 of human α1-microglobulin or / and a sequence of at least 6 amino acids from the partial amino acid sequence between amino acids 1 and 20 of human α1 microglobulin. An antibody according to the invention is specifically capable of binding both with one of the peptides according to the invention and with human α1-microglobulin. For the determination of human α1-microglobulin in a sample liquid by an immunoassay, the sample liquid is brought into contact simultaneously or sequentially with defined amounts of the components antibody and peptide, one of the components being marked and the determination being made via this marking. <IMAGE> |
priorityDate |
1990-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |